Overall, our findings demonstrate that, in the context of KPC tumors, loss of the muscle-specific E3 ubiquitin ligase, MuRF1, protects against skeletal muscle and fat wasting, prevents skeletal muscle dysfunction, slows the rate of tumor growth, and extends survival. Here, TRIM63 is linked to neoplasm.